Dr Hill on the Use of Carfilzomib With R-CHOP in DLBCL

Brian T. Hill, MD, PhD, discusses the final results from a phase 1/2 trial of carfilzomib given with R-CHOP in the frontline setting for patients with non-germinal center diffuse large B-cell lymphoma.

Related Keywords

Briant Hill , ,Cleveland Clinic Taussig Cancer Institute ,Lymphoid Malignancies Program ,Cleveland Clinic ,Onclive Tv ,Hematologic Malignancies ,Nct02073097 ,